SALA, GIANLUCA
 Distribuzione geografica
Continente #
EU - Europa 844
NA - Nord America 208
AS - Asia 103
AF - Africa 1
Totale 1.156
Nazione #
FR - Francia 351
US - Stati Uniti d'America 206
SE - Svezia 195
IT - Italia 180
IE - Irlanda 55
VN - Vietnam 44
CN - Cina 15
IN - India 12
NL - Olanda 12
CZ - Repubblica Ceca 9
DE - Germania 9
HK - Hong Kong 8
KR - Corea 7
PH - Filippine 7
RU - Federazione Russa 7
UA - Ucraina 7
BE - Belgio 5
RO - Romania 5
GB - Regno Unito 4
IR - Iran 3
JP - Giappone 3
MY - Malesia 3
CA - Canada 2
PL - Polonia 2
AT - Austria 1
BY - Bielorussia 1
PT - Portogallo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.156
Città #
Stockholm 194
Chieti 98
Paris 62
Dublin 55
Ashburn 44
Dong Ket 42
Boardman 38
Rome 11
Redmond 10
San Jose 9
Milan 7
Mumbai 7
Beijing 6
Central 6
Treviso 6
Brussels 4
Dallas 4
Fleming Island 4
Parma 4
Pescara 4
Poway 4
Angeles City 3
Barrington 3
Brooklyn 3
Council Bluffs 3
Craiova 3
Frankfurt am Main 3
Houston 3
Kuala Lumpur 3
London 3
Nerviano 3
Ugong Norte 3
Wuhan 3
Amsterdam 2
Ann Arbor 2
Bengaluru 2
Fagnano Olona 2
Gorzkow 2
Hanoi 2
Kobe 2
Lanciano 2
L’Aquila 2
Mulazzano 2
Noci 2
Pioltello 2
San Diego 2
Tehran 2
Toronto 2
Andover 1
Arezzo 1
Auburn 1
Austin 1
Basking Ridge 1
Berlin 1
Brest 1
Brignais 1
Bucharest 1
Buyeo 1
Cape Town 1
Chicago 1
Dearborn 1
Fort Lee 1
Galati 1
Gatchina 1
Herselt 1
Innsbruck 1
Kochi 1
Lake Forest 1
Lecco 1
Lequile 1
Los Angeles 1
Maarssen 1
Malmo 1
Melito Di Napoli 1
Memphis 1
New York 1
Norwalk 1
Nürnberg 1
Osimo 1
Padova 1
Pasig 1
Piedimonte 1
Portici 1
Portimão 1
Pune 1
San Paolo 1
San Salvo 1
Santa Clara 1
Seattle 1
Shenyang 1
Shrewsbury 1
Suwon 1
Suzhou 1
Taipei 1
Turin 1
Utrecht 1
Verona 1
Vicenza 1
Voorhees Township 1
Watertown 1
Totale 737
Nome #
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer, file e4233f18-e93d-2860-e053-6605fe0a460a 205
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors, file e4233f18-9584-2860-e053-6605fe0a460a 85
Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model, file e4233f16-e784-2860-e053-6605fe0a460a 75
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling., file e4233f14-fc88-2860-e053-6605fe0a460a 64
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates, file e4233f17-0528-2860-e053-6605fe0a460a 40
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac, file e4233f17-65ca-2860-e053-6605fe0a460a 38
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies, file e4233f17-9070-2860-e053-6605fe0a460a 37
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes, file e4233f17-4b33-2860-e053-6605fe0a460a 35
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration, file e4233f18-9550-2860-e053-6605fe0a460a 35
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance, file e4233f15-4484-2860-e053-6605fe0a460a 28
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma, file e4233f16-e783-2860-e053-6605fe0a460a 27
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma, file e4233f17-7c4c-2860-e053-6605fe0a460a 27
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma, file e4233f17-8230-2860-e053-6605fe0a460a 27
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation, file e4233f17-828e-2860-e053-6605fe0a460a 27
Antibody-drug conjugates: The new frontier of chemotherapy, file e4233f17-d812-2860-e053-6605fe0a460a 26
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review, file e4233f18-b812-2860-e053-6605fe0a460a 26
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines, file e4233f17-7e3d-2860-e053-6605fe0a460a 23
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy, file e4233f18-4704-2860-e053-6605fe0a460a 21
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages, file e4233f15-4490-2860-e053-6605fe0a460a 20
HER-3: Hub for escape mechanisms, file e4233f17-868b-2860-e053-6605fe0a460a 20
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications, file ad221ea8-7481-49fb-87f1-0833300bc915 19
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer, file e4233f18-8d61-2860-e053-6605fe0a460a 19
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma, file e4233f18-51bf-2860-e053-6605fe0a460a 18
MYC regulates metabolism through vesicular transfer of glycolytic kinases, file e4233f18-8cae-2860-e053-6605fe0a460a 18
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET, file 3b7de6c7-ad99-4c24-a0bc-07418603358a 17
P63 role in breast cancer, file e4233f17-7b2f-2860-e053-6605fe0a460a 17
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors, file e4233f18-4732-2860-e053-6605fe0a460a 17
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer, file e4233f18-ca41-2860-e053-6605fe0a460a 16
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer, file e4233f17-e4be-2860-e053-6605fe0a460a 15
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer, file e4233f16-dfd1-2860-e053-6605fe0a460a 14
Breast cancer in the era of integrating "Omics" approaches, file e4233f19-2512-2860-e053-6605fe0a460a 13
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma, file b5a2d813-9694-474b-b6b6-8c6087c42654 12
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation, file e4233f17-86d3-2860-e053-6605fe0a460a 11
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth, file e4233f19-4807-2860-e053-6605fe0a460a 11
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans, file e4233f18-f07d-2860-e053-6605fe0a460a 7
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma, file 964f00b4-a892-436e-b396-946d6d41f49f 5
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma, file a289b249-cb14-4c5e-b641-511a38584754 5
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target, file b81e5c5f-a118-4da4-a6b3-237f50c2d07c 5
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine, file e4233f17-f5fe-2860-e053-6605fe0a460a 5
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers, file 48ed67ca-8a5f-4a37-a619-acf5fc7cfc90 4
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo., file 5a50a26e-3c0b-49e6-872f-11fd81f9a2f3 4
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target, file 7c19329b-fd7d-4917-a573-5a2064ea8924 4
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction., file e4233f18-3ea2-2860-e053-6605fe0a460a 4
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer, file 77a5d360-257e-4d44-b501-20f7c733e6de 3
ERBB3 BINDING ANTIBODY, file e4233f16-d5ab-2860-e053-6605fe0a460a 2
Negative regulation of receptor tyrosine kinase signals, file e4233f17-7f61-2860-e053-6605fe0a460a 2
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1, file e4233f17-867b-2860-e053-6605fe0a460a 2
ABCC3 is a novel target for the treatment of pancreatic cancer, file e4233f17-eac9-2860-e053-6605fe0a460a 2
Phospholipase Cgamma1 is required for metastasis development and progression, file e4233f14-f102-2860-e053-6605fe0a460a 1
Totale 1.158
Categoria #
all - tutte 3.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/202034 0 0 5 4 1 2 1 0 3 8 9 1
2020/202170 1 1 1 1 4 1 1 5 2 6 4 43
2021/202299 5 4 19 2 9 6 8 3 10 5 14 14
2022/2023372 6 4 5 14 6 44 71 28 29 53 101 11
2023/2024577 16 16 27 62 46 260 35 17 98 0 0 0
Totale 1.158